Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut BAZ1B 9031 broad.mit.edu 37 7 72861634 72861634 + Silent SNP C C T TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr7:72861634C>T uc003tyc.3 - 15 4156 c.3804G>A c.(3802-3804)gaG>gaA p.E1268E NM_032408 NP_115784 Q9UIG0 BAZ1B_HUMAN Homo sapiens bromodomain adjacent to zinc finger domain, 1B (BAZ1B), mRNA. 1268 Poly-Glu. ATP-dependent chromatin remodeling|DNA replication-dependent nucleosome disassembly|chromatin-mediated maintenance of transcription|double-strand break repair|heart morphogenesis|transcription, DNA-dependent WINAC complex ATP binding|chromatin binding|histone acetyl-lysine binding|histone kinase activity|non-membrane spanning protein tyrosine kinase activity|protein complex scaffold|vitamin D receptor activator activity|vitamin D receptor binding|zinc ion binding NS(1)|breast(5)|cervix(1)|endometrium(5)|kidney(5)|large_intestine(12)|lung(20)|ovary(5)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 61 Lung NSC(55;0.0659)|all_lung(88;0.152) cctcctcctcctcttcttcct 0.438000 4 109 0 0 1 0 0 SRPX2 27286 broad.mit.edu 37 X 99920610 99920610 + Missense_Mutation SNP G G A rs146063801 byFrequency TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chrX:99920610G>A uc004egb.3 + 6 1217 c.737G>A c.(736-738)cGa>cAa p.R246Q NM_014467 NP_055282 O60687 SRPX2_HUMAN Homo sapiens sushi-repeat containing protein, X-linked 2 (SRPX2), mRNA. 246 HYR. angiogenesis|cell motility|cell-cell adhesion|positive regulation of cell migration involved in sprouting angiogenesis|regulation of phosphorylation cytoplasm|extracellular region receptor binding endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(1)|lung(10)|ovary(2)|upper_aerodigestive_tract(1) 19 GCCTATGACCGAGCCTACAAC 0.488000 105 194 0 0 1 0 0 FBXO10 26267 broad.mit.edu 37 9 37537802 37537802 + Missense_Mutation SNP C C T TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr9:37537802C>T uc004aac.3 - 2 852 c.772G>A c.(772-774)Gtc>Atc p.V258I FBXO10_uc004aab.3_Missense_Mutation_p.V242I|FBXO10_uc004aad.3_Intron NM_012166 NP_036298 Q9UK96 FBX10_HUMAN Homo sapiens F-box protein 10 (FBXO10), mRNA. 242 ubiquitin ligase complex ubiquitin-protein ligase activity breast(1)|endometrium(5)|large_intestine(11)|lung(15)|prostate(1)|upper_aerodigestive_tract(1) 34 GBM - Glioblastoma multiforme(29;0.0107) TTTTCCAGGACACACAGGGGC 0.498000 27 56 0 0 1 0 0 ZNF16 7564 broad.mit.edu 37 8 146156288 146156288 + Missense_Mutation SNP A A G TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr8:146156288A>G uc003zet.3 - 3 2072 c.1885T>C c.(1885-1887)Tac>Cac p.Y629H ZNF16_uc003zeu.3_Missense_Mutation_p.Y629H NM_001029976 NP_008889 P17020 ZNF16_HUMAN Homo sapiens zinc finger protein 16 (ZNF16), transcript variant 2, mRNA. 629 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding breast(2)|endometrium(1)|kidney(4)|large_intestine(5)|lung(9)|ovary(5)|prostate(1)|skin(1)|urinary_tract(1) 29 all_cancers(97;8.72e-12)|all_epithelial(106;1.07e-10)|Lung NSC(106;7.18e-05)|all_lung(105;0.00021)|Ovarian(258;0.0173)|Acute lymphoblastic leukemia(118;0.155) Acute lymphoblastic leukemia(644;0.136) Epithelial(56;3.45e-38)|all cancers(56;3.04e-33)|BRCA - Breast invasive adenocarcinoma(115;0.0424)|Colorectal(110;0.055) GBM - Glioblastoma multiforme(99;0.02)|KIRC - Kidney renal clear cell carcinoma(644;0.0486) CTGCATTTGTAGGGGCGCTCG 0.537000 4 150 0 0 1 0 0 DDX51 317781 broad.mit.edu 37 12 132625900 132625900 + Silent SNP C C T TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr12:132625900C>T uc001ujy.4 - 7 1209 c.1170G>A c.(1168-1170)gcG>gcA p.A390A NM_175066 NP_778236 Q8N8A6 DDX51_HUMAN Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 (DDX51), mRNA. 390 Helicase ATP-binding. rRNA processing nucleolus ATP binding|ATP-dependent helicase activity|RNA binding endometrium(1)|lung(5)|ovary(2)|pancreas(1)|upper_aerodigestive_tract(1) 10 all_neural(191;0.0982)|Medulloblastoma(191;0.163) all_epithelial(31;0.241) OV - Ovarian serous cystadenocarcinoma(86;7.59e-08)|Epithelial(86;3.62e-07)|all cancers(50;2.13e-05) GGAAGGCGGCCGCCACCACCC 0.687000 91 159 0 0 1 0 0 CBX6 23466 broad.mit.edu 37 22 39262611 39262611 + Missense_Mutation SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr22:39262611G>A uc003awl.3 - 4 905 c.842C>T c.(841-843)cCt>cTt p.P281L NM_014292 NP_055107 O95503 CBX6_HUMAN Homo sapiens chromobox homolog 6 (CBX6), mRNA. 281 chromatin modification|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent PcG protein complex large_intestine(1)|lung(3)|skin(1)|upper_aerodigestive_tract(1) 6 Melanoma(58;0.04) CTGTGGTGTAGGCGAGGGGCA 0.746000 13 11 0 0 1 0 0 NXF3 56000 broad.mit.edu 37 X 102339349 102339349 + Missense_Mutation SNP T T A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chrX:102339349T>A uc004eju.3 - 2 343 c.272A>T c.(271-273)gAg>gTg p.E91V NXF3_uc010noi.1_5'Flank|NXF3_uc011mrw.1_Missense_Mutation_p.E91V|NXF3_uc011mrx.1_Missense_Mutation_p.E2V NM_022052 NP_071335 Q9H4D5 NXF3_HUMAN Homo sapiens nuclear RNA export factor 3 (NXF3), mRNA. 91 cytoplasm|nuclear RNA export factor complex nucleocytoplasmic transporter activity|nucleotide binding|protein binding NS(1)|central_nervous_system(1)|cervix(1)|kidney(1)|large_intestine(2)|lung(15)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1) 26 TTGCTCTCTCTCCATGTTAAC 0.478000 111 173 0 0 1 0 0 DLC1 10395 broad.mit.edu 37 8 12957624 12957624 + Missense_Mutation SNP C C G TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr8:12957624C>G uc003wwm.2 - 8 2666 c.2222G>C c.(2221-2223)aGc>aCc p.S741T DLC1_uc003wwk.1_Missense_Mutation_p.S304T|DLC1_uc003wwl.1_Missense_Mutation_p.S338T|DLC1_uc011kxx.1_Missense_Mutation_p.S230T NM_182643 NP_872584 Q96QB1 RHG07_HUMAN Homo sapiens deleted in liver cancer 1 (DLC1), transcript variant 1, mRNA. 741 Poly-Ser. actin cytoskeleton organization|activation of caspase activity|focal adhesion assembly|forebrain development|heart morphogenesis|hindbrain morphogenesis|induction of apoptosis|negative regulation of Rho protein signal transduction|negative regulation of cell migration|negative regulation of cell proliferation|negative regulation of stress fiber assembly|neural tube closure|positive regulation of protein dephosphorylation|regulation of cell shape|small GTPase mediated signal transduction caveola|cytosol|focal adhesion|nucleus Rho GTPase activator activity|SH2 domain binding NS(2)|breast(2)|cervix(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(39)|lung(32)|ovary(4)|pancreas(2)|prostate(4)|skin(2)|stomach(2)|upper_aerodigestive_tract(5)|urinary_tract(1) 110 GCTGCTGCTGCTGGTCTGCGT 0.627000 4 98 0 0 1 0 0 SLC5A2 6524 broad.mit.edu 37 16 31500259 31500259 + Missense_Mutation SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr16:31500259G>A uc002ecf.4 + 10 1358 c.1339G>A c.(1339-1341)Gca>Aca p.A447T SLC5A2_uc010car.3_Intron|C16orf58_uc002ecg.3_Non-coding_Transcript NM_003041 NP_003032 P31639 SC5A2_HUMAN Homo sapiens solute carrier family 5 (sodium/glucose cotransporter), member 2 (SLC5A2), mRNA. 447 carbohydrate metabolic process integral to membrane low-affinity glucose:sodium symporter activity endometrium(2)|kidney(3)|large_intestine(5)|lung(9)|ovary(1)|pancreas(1)|prostate(2)|skin(1)|urinary_tract(1) 25 GGTGCAGGCGGCACAGGGCGG 0.682000 4 126 0 0 1 0 0 CACNA2D3 55799 broad.mit.edu 37 3 54919331 54919331 + Missense_Mutation SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr3:54919331G>A uc003dhf.3 + 21 1984 c.1936G>A c.(1936-1938)Gat>Aat p.D646N CACNA2D3_uc011beu.1_Non-coding_Transcript|CACNA2D3_uc003dhg.1_Missense_Mutation_p.D552N|CACNA2D3_uc003dhh.1_Non-coding_Transcript|CACNA2D3_uc010hmv.1_Missense_Mutation_p.D380N|AK092143_uc003dhk.1_Intron NM_018398 NP_060868 Q8IZS8 CA2D3_HUMAN Homo sapiens calcium channel, voltage-dependent, alpha 2/delta subunit 3 (CACNA2D3), mRNA. 646 integral to membrane calcium channel activity|metal ion binding|voltage-gated ion channel activity NS(1)|breast(3)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(17)|lung(17)|ovary(1)|prostate(1)|skin(5)|stomach(1)|urinary_tract(3) 59 KIRC - Kidney renal clear cell carcinoma(284;0.00287)|Kidney(284;0.00327) AGAACATCCCGATGTGTCCTT 0.483000 50 86 0 0 1 0 0 NCOA6 23054 broad.mit.edu 37 20 33338270 33338270 + Silent SNP C C T TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr20:33338270C>T uc002xav.3 - 9 4299 c.1728G>A c.(1726-1728)ccG>ccA p.P576P NCOA6_uc002xaw.3_Silent_p.P576P|NCOA6_uc021wcd.1_Silent_p.P576P|NCOA6_uc021wce.1_Silent_p.P576P|NCOA6_uc021wcf.1_Silent_p.P576P NM_014071 NP_054790 Q14686 NCOA6_HUMAN Homo sapiens nuclear receptor coactivator 6 (NCOA6), transcript variant 1, mRNA. 576 CREBBP-binding region.|Gln-rich.|NCOA1-binding region.|TBP/GTF2A-binding region. DNA recombination|DNA repair|DNA replication|brain development|cellular lipid metabolic process|estrogen receptor signaling pathway|glucocorticoid receptor signaling pathway|heart development|myeloid cell differentiation|positive regulation of transcription from RNA polymerase II promoter|response to hormone stimulus|transcription initiation from RNA polymerase II promoter transcription factor complex chromatin binding|enzyme binding|estrogen receptor binding|ligand-dependent nuclear receptor transcription coactivator activity|retinoid X receptor binding|thyroid hormone receptor binding p.G575W(1) NS(2)|breast(6)|central_nervous_system(3)|cervix(1)|endometrium(9)|kidney(8)|large_intestine(16)|lung(37)|ovary(4)|prostate(5)|skin(13)|upper_aerodigestive_tract(2)|urinary_tract(1) 107 TCATATTTGGCGGCCCGTGGG 0.453000 4 135 0 0 1 0 0 NLRP5 126206 broad.mit.edu 37 19 56539568 56539568 + Missense_Mutation SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr19:56539568G>A uc002qmj.3 + 6 1969 c.1969G>A c.(1969-1971)Gtt>Att p.V657I NLRP5_uc002qmi.3_Missense_Mutation_p.V638I NM_153447 NP_703148 P59047 NALP5_HUMAN Homo sapiens NLR family, pyrin domain containing 5 (NLRP5), mRNA. 657 mitochondrion|nucleolus ATP binding p.V657I(2) breast(1)|central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(8)|ovary(5)|skin(2)|stomach(4)|upper_aerodigestive_tract(2) 25 Colorectal(82;3.46e-05)|Ovarian(87;0.0481)|Renal(1328;0.157) GBM - Glioblastoma multiforme(193;0.0326) GGGCTGTCCCGTTCCCCTGGG 0.597000 50 76 0 0 1 0 0 HBXIP 10542 broad.mit.edu 37 1 110950445 110950445 + Missense_Mutation SNP C C T TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr1:110950445C>T uc001dzr.3 - 0 102 c.44G>A c.(43-45)aGc>aAc p.S15N NM_006402 NP_006393 O43504 HBXIP_HUMAN Homo sapiens hepatitis B virus x interacting protein (HBXIP), mRNA. 15 anti-apoptosis|negative regulation of caspase activity|response to virus|viral genome replication cytosol protein binding kidney(1)|large_intestine(3)|lung(1)|ovary(1)|pancreas(1)|prostate(1)|skin(1) 9 all_cancers(81;4.08e-06)|all_epithelial(167;4.38e-06)|all_lung(203;0.000152)|Lung NSC(277;0.000301) Lung(183;0.0237)|all cancers(265;0.0675)|Epithelial(280;0.0732)|Colorectal(144;0.102)|LUSC - Lung squamous cell carcinoma(189;0.134) AAGGCTTGGGCTCCCCGCGCG 0.627000 33 41 0 0 1 0 0 KCNA7 3743 broad.mit.edu 37 19 49575500 49575500 + Missense_Mutation SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr19:49575500G>A uc002pmg.3 - 0 699 c.343C>T c.(343-345)Ccg>Tcg p.P115S NM_031886 NP_114092 Q96RP8 KCNA7_HUMAN Homo sapiens potassium voltage-gated channel, shaker-related subfamily, member 7 (KCNA7), mRNA. 115 voltage-gated potassium channel complex voltage-gated potassium channel activity central_nervous_system(1)|endometrium(2)|large_intestine(2)|lung(4)|skin(2) 11 all_lung(116;1.7e-06)|Lung NSC(112;3.55e-06)|all_epithelial(76;3.83e-06)|all_neural(266;0.0189)|Ovarian(192;0.0261) all cancers(93;0.000397)|OV - Ovarian serous cystadenocarcinoma(262;0.000519)|GBM - Glioblastoma multiforme(486;0.00541)|Epithelial(262;0.0441) CGCTCGGGCGGCACCGGGCAG 0.746000 3 37 0 0 1 0 0 SEL1L2 80343 broad.mit.edu 37 20 13850192 13850192 + Silent SNP T T C TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr20:13850192T>C uc010gcf.3 - 13 1294 c.1212A>G c.(1210-1212)aaA>aaG p.K404K SEL1L2_uc002woq.4_Silent_p.K265K|SEL1L2_uc010zrl.2_Silent_p.K404K|SEL1L2_uc002wor.3_Non-coding_Transcript NM_025229 NP_079505 Q5TEA6 SE1L2_HUMAN Homo sapiens sel-1 suppressor of lin-12-like 2 (C. elegans) (SEL1L2), mRNA. 404 integral to membrane binding cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(14)|lung(25)|ovary(2)|skin(3)|urinary_tract(1) 51 CGGGCCACCCTTTTTCCGCAG 0.393000 3 111 0 0 1 0 0 JAK2 3717 broad.mit.edu 37 9 5044418 5044418 + Silent SNP T T C TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr9:5044418T>C uc010mhm.3 + 3 479 c.366T>C c.(364-366)cgT>cgC p.R122R JAK2_uc003ziw.3_Silent_p.R122R NM_004972 NP_004963 O60674 JAK2_HUMAN Homo sapiens Janus kinase 2 (JAK2), mRNA. 122 FERM.|Interaction with cytokine/interferon/growth hormone receptors (By similarity). JAK-STAT cascade involved in growth hormone signaling pathway|STAT protein import into nucleus|actin filament polymerization|activation of JAK2 kinase activity|activation of caspase activity by protein phosphorylation|blood coagulation|cellular component movement|erythrocyte differentiation|interferon-gamma-mediated signaling pathway|interleukin-12-mediated signaling pathway|mammary gland epithelium development|mesoderm development|negative regulation of DNA binding|negative regulation of cell proliferation|positive regulation of apoptosis|positive regulation of cell-substrate adhesion|positive regulation of growth hormone receptor signaling pathway|positive regulation of nitric-oxide synthase 2 biosynthetic process|positive regulation of phosphatidylinositol 3-kinase cascade|positive regulation of tumor necrosis factor production|positive regulation of tyrosine phosphorylation of Stat3 protein|positive regulation of tyrosine phosphorylation of Stat5 protein|protein autophosphorylation|regulation of inflammatory response|regulation of interferon-gamma-mediated signaling pathway|response to antibiotic|response to lipopolysaccharide|tumor necrosis factor-mediated signaling pathway|tyrosine phosphorylation of STAT protein caveola|cytoskeleton|cytosol|endomembrane system|nucleus ATP binding|SH2 domain binding|growth hormone receptor binding|heme binding|histone binding|histone kinase activity (H3-Y41 specific)|interleukin-12 receptor binding|non-membrane spanning protein tyrosine kinase activity|protein kinase binding BCR/JAK2(6)|SSBP2/JAK2(4)|SEC31A/JAK2(4)|ETV6/JAK2(11)|PCM1/JAK2(30)|PAX5/JAK2(18) breast(5)|endometrium(4)|haematopoietic_and_lymphoid_tissue(32944)|kidney(4)|large_intestine(10)|liver(1)|lung(20)|ovary(3)|prostate(4)|skin(2)|urinary_tract(1) 32998 all_hematologic(13;0.137) Acute lymphoblastic leukemia(23;0.0198)|Breast(48;0.147) GBM - Glioblastoma multiforme(50;0.0237)|Lung(218;0.133) ACTTTCCTCGTTGGTATTGCA 0.393000 1 """T, Mis, O""" """ETV6, PCM1, BCR""" """ALL, AML, MPD, CML""" Polycythemia Vera, Familial 3 138 0 0 1 0 0 ITGAV 3685 broad.mit.edu 37 2 187532443 187532443 + Silent SNP G G A TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr2:187532443G>A uc002upq.3 + 23 2649 c.2373G>A c.(2371-2373)gaG>gaA p.E791E ITGAV_uc010frs.3_Silent_p.E755E|ITGAV_uc010zfv.2_Silent_p.E745E NM_002210 NP_002201 P06756 ITAV_HUMAN Homo sapiens integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV), transcript variant 1, mRNA. 791 ERK1 and ERK2 cascade|angiogenesis|axon guidance|blood coagulation|cell-matrix adhesion|entry of bacterium into host cell|entry of symbiont into host cell by promotion of host phagocytosis|entry of virus into host cell|integrin-mediated signaling pathway|leukocyte migration|negative regulation of apoptosis|negative regulation of lipid storage|negative regulation of lipid transport|negative regulation of lipoprotein metabolic process|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of macrophage derived foam cell differentiation|positive regulation of cell adhesion|positive regulation of cell proliferation|regulation of apoptotic cell clearance integrin complex receptor activity|transforming growth factor beta binding breast(3)|central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(6)|lung(19)|ovary(2)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(3) 47 OV - Ovarian serous cystadenocarcinoma(117;0.0185)|Epithelial(96;0.072)|all cancers(119;0.189) STAD - Stomach adenocarcinoma(3;0.106)|COAD - Colon adenocarcinoma(31;0.108) CAAACTGGGAGCACAAGGAGA 0.418000 4 172 0 0 1 0 0 BRAF 673 broad.mit.edu 37 7 140453136 140453136 + Missense_Mutation SNP A A T rs121913377 TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chr7:140453136A>T uc003vwc.4 - 14 1860 c.1799T>A c.(1798-1800)gTg>gAg p.V600E NM_004333 NP_004324 P15056 BRAF_HUMAN Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF), mRNA. 600 Protein kinase. V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis). activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission cytosol|nucleus|plasma membrane ATP binding|metal ion binding p.V600E(41204)|p.V600K(615)|p.V600?(377)|p.V600R(99)|p.V600D(40)|p.V600_K601>E(30)|p.V600L(28)|p.V600A(24)|p.V600G(22)|p.V600M(22)|p.A598_T599insV(7)|p.T599_V600insT(7)|p.T599I(5)|p.V600Q(4)|p.T599_R603>I(4)|p.T599_V600insTT(3)|p.T599_V600insDFGLAT(2)|p.T599_V600>IAL(2)|p.V600_S605>EK(2)|p.T599T(2)|p.V600_S605>DV(2)|p.V600_S605>D(2)|p.V600_W604del(1)|p.V600V(1)|p.T599_V600insV(1)|p.V600>DLAT(1)|p.D594_T599del(1) SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2) NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3) 27380 Melanoma(164;0.00956) Sorafenib(DB00398) TCGAGATTTCACTGTAGCTAG 0.368000 V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN) 61 """Mis, T, O""" """AKAP9, KIAA1549""" """melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma""" Cardio-facio-cutaneous syndrome Cardiofaciocutaneous syndrome 37 57 0 0 1 0 0 TAF1 6872 broad.mit.edu 37 X 70598838 70598838 + Silent SNP T T C TCGA-EL-A3N2-01A-11D-A20C-08 TCGA-EL-A3N2-11A-11D-A20C-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5f84a779-b700-4702-b234-39c737bc0d0c e7aeb5ff-8428-4949-a030-0b0463322b6a g.chrX:70598838T>C uc004dzt.4 + 7 1428 c.1377T>C c.(1375-1377)ccT>ccC p.P459P BCYRN1_uc011mpt.1_Intron|TAF1_uc004dzu.4_Silent_p.P438P NM_004606 NP_004597 P21675 TAF1_HUMAN Homo sapiens TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa (TAF1), transcript variant 1, mRNA. 438 G1 phase of mitotic cell cycle|RNA polymerase II transcriptional preinitiation complex assembly|interspecies interaction between organisms|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription initiation from RNA polymerase II promoter|protein autophosphorylation|regulation of transcription involved in G2/M-phase of mitotic cell cycle|transcription elongation from RNA polymerase II promoter|viral reproduction MLL1 complex|transcription factor TFIID complex ATP binding|TBP-class protein binding|histone acetyl-lysine binding|histone acetyltransferase activity|p53 binding|protein binding|protein serine/threonine kinase activity|sequence-specific DNA binding|transcription coactivator activity p.L458V(1) breast(13)|central_nervous_system(6)|cervix(1)|endometrium(25)|haematopoietic_and_lymphoid_tissue(2)|kidney(6)|large_intestine(16)|lung(34)|ovary(9)|prostate(3)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(3) 124 Renal(35;0.156) all_lung(315;0.000321) GCTGGCTTCCTTCTAGCATGA 0.498000 5 287 0 0 1 0 0